Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
US7838251B2 · kind B2 · utility
0Cited by
10References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 22, 2008 |
| Grant date | Nov 23, 2010 |
| Priority date | — |
| Expiry date | Dec 7, 2028 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/57419
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Proteins useful in the diagnosis of proliferative disorders of the colon are present in nuclear matrix protein preparations and can be characterized by molecular weight, isoelectric point, and amino acid sequence. The proteins may be identified, for example, by 2D-gel electrophoresis or by specific binding partners, such as antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.